user

BRAF V600E Inhibition in Anaplastic Thyroid Cancer

被引：139
|
作者：
Rosove, Michael H. [1 ]
Peddi, Parvin F. [1 ]
Glaspy, John A. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 07期
关键词：
DIFFERENTIATED CARCINOMAS; MUTATION;
D O I：
10.1056/NEJMc1215697
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：684 / 685
页数：2
相关论文
共 50 条
  • [41] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Sun, Chong
    Wang, Liqin
    Huang, Sidong
    Heynen, Guus J. J. E.
    Prahallad, Anirudh
    Robert, Caroline
    Haanen, John
    Blank, Christian
    Wesseling, Jelle
    Willems, Stefan M.
    Zecchin, Davide
    Hobor, Sebastijan
    Bajpe, Prashanth K.
    Lieftink, Cor
    Mateus, Christina
    Vagner, Stephan
    Grernrum, Wipawadee
    Hofland, Ingrid
    Schlicker, Andreas
    Wessels, Lodewyk F. A.
    Beijersbergen, Roderick L.
    Bardelli, Alberto
    Di Nicolantonio, Federica
    Eggermont, Alexander M. M.
    Bernards, Rene
    NATURE, 2014, 508 (7494) : 118 - +
  • [42] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Chong Sun
    Liqin Wang
    Sidong Huang
    Guus J. J. E. Heynen
    Anirudh Prahallad
    Caroline Robert
    John Haanen
    Christian Blank
    Jelle Wesseling
    Stefan M. Willems
    Davide Zecchin
    Sebastijan Hobor
    Prashanth K. Bajpe
    Cor Lieftink
    Christina Mateus
    Stephan Vagner
    Wipawadee Grernrum
    Ingrid Hofland
    Andreas Schlicker
    Lodewyk F. A. Wessels
    Roderick L. Beijersbergen
    Alberto Bardelli
    Federica Di Nicolantonio
    Alexander M. M. Eggermont
    Rene Bernards
    Nature, 2014, 508 : 118 - 122
  • [43] Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
    Xing, Mingzhao
    Alzahrani, Ali S.
    Carson, Kathryn A.
    Viola, David
    Elisei, Rossella
    Bendlova, Bela
    Yip, Linwah
    Mian, Caterina
    Vianello, Federica
    Tuttle, R. Michael
    Robenshtok, Eyal
    Fagin, James A.
    Puxeddu, Efisio
    Fugazzola, Laura
    Czarniecka, Agnieszka
    Jarzab, Barbara
    O'Neill, Christine J.
    Sywak, Mark S.
    Lam, Alfred K.
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    Nakayama, Hirotaka
    Tufano, Ralph P.
    Pai, Sara I.
    Zeiger, Martha A.
    Westra, William H.
    Clark, Douglas P.
    Clifton-Bligh, Roderick
    Sidransky, David
    Ladenson, Paul W.
    Sykorova, Vlasta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (14): : 1493 - 1501
  • [44] MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation
    Celakovsky, Petr
    Kovarikova, Helena
    Chrobok, Viktor
    Mejzlik, Jan
    Laco, Jan
    Vosmikova, Hana
    Chmelarova, Marcela
    Ryska, Ales
    IN VIVO, 2021, 35 (01): : 319 - 323
  • [45] DNA methylation profile in papillary thyroid cancer according to BRAF (V600E) mutation
    Beltrami, Caroline Moraes
    dos Reis, Mariana Bisarro
    Barros-Filho, Mateus Camargo
    Marchi, Fabio Albuquerque
    Kuasne, Hellen
    Ambatipudi, Srikant
    Herceg, Zdenko
    Kowalski, Luiz Paulo
    Rogatto, Silvia Regina
    CANCER RESEARCH, 2015, 75
  • [46] BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer
    Groener, Jan Benedikt
    Gelen, Debora
    Mogler, Carolin
    Herpel, Esther
    Toth, Csaba
    Kender, Zoltan
    Peichl, Marco
    Haufe, Sabine
    Haberkorn, Uwe
    Sulaj, Alba
    Zemva, Johanna
    Kopf, Stefan
    Nawroth, Peter Paul
    Brune, Maik
    Rudofsky, Gottfried
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 69 - 75
  • [47] The Impact of BRAF V600E Mutation Allele Frequency on the Histopathological Characteristics of Thyroid Cancer
    Abdulhaleem, Mawaddah
    Bandargal, Saruchi
    Pusztaszeri, Marc Philippe
    Rajab, Mohannad
    Greenspoon, Hannah
    Krasner, Joshua Ross
    Da Silva, Sabrina Daniela
    Forest, Veronique-Isabelle
    Payne, Richard J.
    CANCERS, 2024, 16 (01)
  • [48] Relationship of body mass index with BRAF V600E mutation in papillary thyroid cancer
    Shi, Rong-liang
    Qu, Ning
    Liao, Tian
    Wei, Wen-jun
    Lu, Zhong-wu
    Ma, Ben
    Wang, Yu-Long
    Ji, Qing-hai
    TUMOR BIOLOGY, 2016, 37 (06) : 8383 - 8390
  • [49] The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer
    Ge, Junshang
    Wang, Jie
    Wang, Hui
    Jiang, Xianjie
    Liao, Qianjin
    Gong, Qian
    Mo, Yongzhen
    Li, Xiaoling
    Li, Guiyuan
    Xiong, Wei
    Zhao, Jin
    Zeng, Zhaoyang
    JOURNAL OF CANCER, 2020, 11 (04): : 932 - 939
  • [50] Genomic profiling and outcomes of BRAF V600E mutated papillary thyroid cancer.
    Shaikh, Hira
    McGrath, Julie
    Brodskiy, Pavel
    Xiu, Joanne
    Ikpeazu, Chukwuemeka
    Leddon, Jennifer
    Sukari, Ammar
    Zandberg, Dan Paul
    Abraham, Jim
    Wise-Draper, Trisha Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18086 - E18086
12345